What is the EndomeTRIO test and when to realize it?

The EndomeTRIO is a non-invasive diagnostic test that includes three advanced tests designed to assess the condition of the endometrium to improve the chances of pregnancy during an in vitro fertilization (IVF) treatment. It includes:

• ERA Test (Endometrial Receptivity Analysis): Designed to assess endometrial receptivity.
• EMMA Test (Endometrial Microbiome Metagenomic Analysis): Analyzes the bacterial composition of the endometrium to evaluate its impact on embryo implantation.
• ALICE Test (Analysis of Infectious Chronic Endometritis): Detects chronic infections in the endometrium that could negatively affect embryo implantation.

What Is the Purpose of the EndomeTRIO Test?

• It personalizes and improves IVF treatments.
• Early detection of imbalances in the endometrial microbiota and chronic infections that could interfere with implantation, allowing specialists to prescribe treatments before starting IVF.
• It identifies the optimal moment for embryo transfer, increasing the chances of success.

When Is the EndomeTRIO Test Recommended?

In case of:

• Repeated implantation failures in previous IVF treatments.
• Recurrent miscarriages with no apparent cause.

How Is the Test Performed?

• The sample is collected via an endometrial biopsy, a quick outpatient procedure that usually does not require anesthesia.
• Results are usually available within 10 to 15 business days after sample collection.

Benefits of the EndomeTRIO Test in Fertility Treatments:

• Personalized treatment: It helps determine the best timing for embryo transfer based on endometrial receptivity.
• Treatment of chronic infections: It identifies and treats infections before implantation, improving pregnancy viability.